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Introduction
At the International Conference on Radiological
Protection of Patients in Diagnostic and Interventional
Radiology, Nuclear Medicine and Radiotherapy, held in
Malaga in April 2001, some authors expressed the opinion
that the system of radiation protection should not be used
with reference to radiotherapy patients. The patient
undergoing radiotherapy procedures, as prescribed by
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I n t r o d u c t i o n.  The paper presents the results of a survey conducted by the Polish Secondary Standard Dosimetry
Laboratory (SSDL) designed to evaluate the development of dosimetry audits in teleradiotherapy in Poland.
M a t e r i a l  a n d  m e t h o d s.  In the years 1991-2001, 151 audits, based on TLD (thermoluminescence detectors) dose
intercomparisons were performed. The participants of the audits were requested to irradiate TL detectors, delivered by the
SSDL, to a predefined dose. The dose was determined with an ionisation chamber in reference conditions. Simultaneously the
SSDL irradiated the TL detectors, with their signal serving as reference.
Re s u l t s.  Deviations exceeding 3.5% (i.e. the acceptance level) were found in 18 cases (nearly 12%). They were analysed and
discussed with the audited participants. It was stated that in 2 cases the errors in dosimetry resulted in over- or underdosage
of a number of patients. In four centres, participating in every audit, the authors detected no deviations exceeding the
acceptance level, and in the last run of the audits (electron beams, 2001) all deviations remained below the acceptance level.
C o n c l u s i o n s.  The results suggest that it is possible to maintain a high standard of measurements with the ionisation
chamber in reference conditions in all centres. The audit programme should be extended to non-standard conditions.
Wyniki auditów dozymetrycznych przeprowadzanych wysy∏kowà metodà TLD w oÊrodkach radioterapii
w Polsce (okres 1991-2001)
W p r o w a d z e n i e. Przedstawiono wyniki dzia∏alnoÊci polskiego Laboratorium Wtórnych Wzorców Dozymetrycznych
(LWWD), majàcej na celu rozwój auditów dozymetrycznych w teleradioterapii w Polsce.
M a t e r i a ∏  i m e t o d y. W latach 1991-2001 przeprowadzono 151 auditów, opartych na porównawczych pomiarach dawek
metodà TLD (detektorów termoluminescencyjnych). Uczestnicy auditów byli proszeni o napromienienie detektorów TL,
dostarczonych przez LWWD, okreÊlonà dawkà. Dawka by∏a wyznaczana za pomocà komory jonizacyjnej w warunkach
referencyjnych. W tym samym czasie LWWD napromieni∏o detektory TL, których sygna∏ by∏ wielkoÊci odniesienia.
W y n i k i. Odchylenia przekraczajàce 3,5% (przyj´te jako poziom dopuszczalny) stwierdzono w 18 przypadkach (ok.12%). By∏y
one analizowane i dyskutowane z uczestnikami auditu. W 2 przypadkach stwierdzono podanie pewnej liczbie pacjentów zbyt
du˝ej lub zbyt ma∏ej dawki w wyniku b∏´du dozymetrycznego. W czterech oÊrodkach, uczestniczàcych we wszystkich auditach,
nie stwierdzono przekroczenia poziomu dopuszczalnego, a ponadto w ostatnim cyklu auditów (wiàzki elektronowe, 2001)
wszystkie odchylenia mia∏y wartoÊç poni˝ej dopuszczalnego poziomu.
W n i o s k i. Wyniki pozwalajà ˝ywiç nadziej´, ˝e zachowanie wysokich standardów pomiarów komorà jonizacyjnà
w warunkach referencyjnych, jest mo˝liwe we wszystkich oÊrodkach. Zasugerowano celowoÊç prowadzenia dalszych auditów,
równie˝ w warunkach niestandardowych.
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the medical practitioner, is protected by the quality
assurance system legally required for medical exposures
[1].
Truly, the objective of radiotherapy is to ensure that
the target volume is given the prescribed dose, while the
dose to surrounding healthy tissues and critical organs is
minimal. The success or failure of radiotherapy depends
upon the accuracy of dose delivery. The accuracy of
dose delivery, which is a complex procedure (from
determination of the doses, through localisation of the
tumour and treatment planning, to the irradiation of the
patient) depends on many factors, and is a major problem
in radiation therapy. It requires elaboration of complex
methodology, a definition of acceptable tolerance levels
for individual parameters, which contribute to the
cumulative effect of radiotherapy procedures, and
organisation of external audits. A detailed quality
assurance system in radiotherapy is presently required
by international and national recommendations [2-4]. It
has been widely recognised that the audit of beam
calibration (determination of the doses in reference
conditions) is a key factor in reducing overall uncertainty
of the radiotherapy chain, and that metrology institutions,
such as the Secondary Standard Dosimetry Laboratories
(SSDL) are usually competent in such activity [5, 6].
In Poland, in 1966 a SSDL was established at the
Medical Physics Department (MPD) of the Institute of
Oncology. In 1988, the Laboratory was approved as
a member of the IAEA/WHO network of SSDLs. This
SSDL has been supported by the IAEA in the framework
of the research contracts and technical assistance, and
has also been regularly audited by the IAEA. The SSDL
plays an important role in supervision of the dosimetry
procedures.
The main activities of the SSDL are:
– collecting data concerning the infrastructure of
radiotherapy in Poland,
– calibration of dosimeters from all radiotherapy
centres in Poland,
– external postal quality audits of dosimetry in
radiotherapy centres in Poland,
– preparation of protocols and recommendations on
dosimetry in radiotherapy,
– training of physicists and radiotherapists in order to
adhere to the increasing complexity of modern
radiotherapy procedures.
As far as the external dosimetry quality audits in
radiotherapy are concerned, the first study of TLD postal
dose inter-comparison in Poland was organised by the
SSDL in 1991 (supported by the IAEA, research contract
no 6013/RB). In 1994, the Polish SSDL joined the
pan-European Radiation Oncology Project for Assurance of
Treatment Quality (EROPAQ). The SSDL participated
in the organisation of the EROPAQ, taking
responsibilities for the organisation of the audit in Poland,
clearing up the deviations of the results beyond acceptable
levels, undertaking corrective actions, and helping to
remeasure and recalculate the doses when necessary. In
1999, the SSDL organised a third postal dose inter-
comparison program for radiotherapy centres in Poland
(supported by the IAEA, research contract no
10796/RO). In 2001 the fourth study started (supported
by the IAEA, research contract 11018/RO). In all these
investigations, described in this paper, the doses were
determined with ionisation chamber measurements in
reference conditions.
In 2000, a special body, the External Audit Group –
EAG (for radiotherapy) was set up at the Medical Physics
Department, as suggested by the IAEA [7, 8]. The EAG,
apart from SSDL representatives, includes medical
physicists, and a radiation oncologist, as it has been
noticed that to gain wide acceptance and collaboration of
the medical centres, it is essential to obtain the approval
of the medical community. The EAG-radiation oncologist
is to be informed of all confirmed major deviations in
dose evaluation and is responsible for notifying the
radiation oncologist from the audited centre.
The major deviations are defined by the inter-
national bodies (IAEA, ESTRO) as such, that might
have a significant negative impact on patient treatment,
while the minor (intermediate) deviations as those, which
occurr beyond the upper limit of acceptable deviations
and below the threshold for major deviations. The
acceptance limits define the maximum acceptable
discrepancies between the doses stated by the audited
participating centre and the doses measured at the
Measuring Laboratory (in our case – the SSDL). These
discrepancies do not require any further investigations,
since there is a high probability that the deviations are
caused by the uncertainty in the audit procedure, rather
than in the statement of the dose by the participant [9,
10]. The acceptance limits of the IAEA/WHO audits for
hospitals are ±5%. These limits are slightly higher than
the entire TLD expanded standard uncertainty (σ=2,3%
and coverage factor k=2) [3, 11]. The acceptance limit of
±5% follows the „classical” tolerance value given by the
ICRU Report 24 [12]. The European Organisation for
Research and Treatment of Cancer (EORTC), throughout
wide investigation covering 357 beams, set an acceptable
level of ±4.0% [13]. The same level was adopted in
a national Swiss investigation [13]. The European Quality
Assurance Network for external radiotherapy defined
the acceptance level corresponding to a deviation <3%,
and the action (intervention) level corresponding to
a deviation >6% (i.e. twice the acceptance level) [15].
The acceptance level used in this study (being also
an intervention level) remains consistent with the
IAEA-audits of the SSDLs, in which the deviations of
±3.5% are considered acceptable [11]. The Polish SSDL
picked an intervention level as low as ±3.5%, which was
possible due to the small number of radiotherapy centres
and easy contact with them.
This paper summarises our studies performed during
the years 1991-2001. They were aimed at testing the
accuracy and consistency of basic dosimetry – calibration
of radiotherapy beams with an ionisation chamber,
in reference conditions. Subsequent steps will cover
dosimetry checks of radiation beams in more complicated
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situations, called non-standard conditions (e.g. including
the estimation of the dose by the radiotherapy treatment
planning systems, measurements outside the central
axis, MLC fields etc.) in which additional errors may
originate.
Material and methods
The participation in the audits was voluntary, but a majority of
centres (70-100% in particular runs) agreed to co-operate. In
order to keep all results confidential each participating centre
was identified by a code number.
The determination of the beam output in gamma beams of
Co-60 units, X-ray and electron beams of linear accelerators
were checked in the listed investigations. The number of audits
performed and the percentage of audited centres from among
those which possessed functioning megavoltage unit at the time
of audits are presented in Table I. As can be seen from our data
a total of three TLD runs for Co-60 units, three for high energy
X-rays, and two TLD runs for electron beams were performed.
In the years 1994-1995 and in 2001 some centres took part in the
audit twice, or checked more than one beam.
Each radiotherapy centre taking part in the audit was
provided with:
– four waterproof perspex capsules filled with lithium fluoride
thermoluminescent virgin powder. LiF powder type MT-F
(Polish production – Institute of Nuclear Physics, Cracow)
was used in the first, third and fourth run, LiF powder type
PTL 717 (French production – Desmarquest CEC) – in the
second run. Each TLD capsule contained an amount of
powder sufficient for 10 independent readings;
– a perspex holder stand, designed and provided by the IAEA,
in which TLD capsules were placed for irradiation;
– an information sheet describing the irradiation procedure;
– a data sheet for reporting the specifications of the treatment
unit and measuring instruments, the method used for
absorbed dose to water determination, coefficients and
factors applied, results of dose measurements, and the details
concerning the irradiation of TLD capsules. This data
allowed to check whether the dosimetry protocol was
properly followed, and to detect possible errors in dose
calculations.
In each investigation the participants were asked to check
the beam output with their dosimeters, and to irradiate the TLD
capsules in sequence, in water phantom, in reference conditions
(using the IAEA perspex holder), to an absorbed dose as
close as possible to 2 Gy. One capsule served as a background
record.
At nearly the same time (within 10 days interval), the SSDL
(Measuring Centre of EROPAQ in the second run) irradiated
the TLD capsules, the signal of which served as the reference. In
the first, third, and fourth runs the TLD readings were evaluated
at the Polish SSDL (with a Harshaw TLD reader), in the second
one, at the EROPAQ Measuring Centre in Leuven (with
a PCL3-Fimel TLD reader). To evaluate the absorbed dose to
water from irradiated TL-detectors, several correction
parameters were investigated and determined (reader's daily
fluctuations, distribution of TL-detectors response, fading,
dependence of TL-detectors response on the heating rate, dose
and energy), and combined uncertainty in dose calculations
determined [16, 17]. The absorbed dose to water was calculated
on the basis of the ionisation chamber measurements (at the
point of the centre of a TLD capsule), in the water phantom,
according to the IAEA TRS 277 dosimetry protocol [18]. The
details on measurement methods were described in earlier
publications [16, 17, 19-21].
The deviation of the dose reported by the participant and
the dose measured by the SSDL were calculated according to the
formula:
Dev (%) = 100 (Dp – DSSDL) / DSSDL                                               (1)
where DSSDL is the dose determined by the SSDL (or
EROPAQ Measuring Centre).
DP is the dose reported by the participant.
Results and Discussion
Figure 1 and Table II presents all deviations, calculated
according to the formula [1]. The deviations exceeding the
acceptable level of 3.5% are marked in bold. The empty
fields indicate that the particular centre did not take part
in the investigation, or had no megavoltage units installed
at that time. If the results were beyond the acceptance
level the representative of the SSDL contacted the
physicists from the participating centres in order to try to
identify the origins of the discrepancies, and to help to
solve problems or difficulties. It was frequently possible to
Table I. The number of TLD dosimetry audits in radiotherapy centers in Poland held between 1991 and 2001
(absorbed dose determination with an ionization chamber in reference conditions)
Years Number of audits
Co-60 photons Linac photons Linac electrons
1991-1993 11 (70%) 11 (70%) 12 (80%)
1994-1995 32 (100%) 24 (100%) –
1999-2000 12 (70%) 17 (90%) –
2001 – – 32 (100%)
Total 55 52 44
The percentage of audited centers from among those, which possessed functioning a megavoltage unit at the time of audits is given in brackets.
Fig. 1. Cumulated distribution of the deviations recorded during
the TLD dosimetry audits in Poland in 1991-2001 (absorbed dose
determination with an ionization chamber in reference conditions)
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Table II. Results of the TLD dosimetry audits in radiotherapy centers in Poland in 1991-2001
The numbers indicate deviations in percent, according to formula /1/
(absorbed dose determination with an ionization chamber in reference conditions)
SSDL EROPAQ SSDL SSDL SSDL
Centre Co-60_91 X_92 e_93 Co-60_94/95 X_94/95 Co-60_99 X_2000 e_2001
Deviations [%]
I 1.0 0.8 1.0 -0.8 1.8 -1.7 -1.7 0.1 -0.3
II 0.4 -2.6 -2.5 1.4 2.2 -2.5 -0.1 -0.1 -0.9 1.6 1.7
III -7.2 -0.5 -1.6 1.7 0.7 -0.7 1.9
IV 1.5 0.9 -4.9 -0.4 4.7 -1.0 -0.6 0.0
V -0.7 -6.4 -2.1 -2.6 1.6 0.9 -1.3 -5.5
VI 12.1 -2.9 0.2 0.5 0.1 0.2 -0.2 2.2 -2.2
VII 2.5 -0.6 2.0 -0.1 -1.7 -0.9 -7.0 -1.5
VIII 4.1 -5.0 -0.3 0.2 2.3
IX 0.4 -3.5 -3.8 -0.5 -2.3 -4.2 -2.9 0.9
X 0.9 -1.0 1.8 0.7 1.0 2.2 -1.8 -0.8 -0.3 0.0 2.4 -1.5 -1.4
XI -0.5 -0.6 2.0 -1.2 -0.4 -0.1 0.3 -4.5 -0.1 -0.1 -0.6 3.1
XII -5.0 -3.2 0.0 0.4 3.1 5.7 -0.3 4.8 -1.2 2.9 0.7 2.7
XIII -1.5 4.7 0.1 1.8 4.2 1.5 -1.1 3.4 -0.6
XIV -3.4 1.3 -4.9 0.3 -2.5 0.0 2.9
XV 0.3 -1.3 0.9 0.8
XVI -2.8 4.3
XVII 2.3 -0.3
XVIII 0.3 1.0 0.1 -2.4 2.0 -0.5
XIX -0.7 1.1 -0.9 0.2 1.9
XX 2.0 -0.8 1.2
XXI 1.7 -0.2 2.9
Table III. Explanation of the discrepancies occurring during the TLD dosimetry audits in Poland between 1991-2001
(absorbed dose determination with an ionization chamber in reference conditions)
Centre Beam Deviation Explanation
III X -7.2 Wrong positioning of the TLDs
IV e -4.9 Unexplained
X 4.7 Unexplained
V X -6.4 Wrong positioning of the TLDs
X -5.5 Unexplained
VI Co-60 12.1 Exposure coefficient Nx instead of absorbed dose coefficient ND was used; some calculation errors
VII X -7.0 Measurements and calculations performed by an inexperienced physicist
VIII X 4.1 Unexplained
X -5.0 Unexplained
IX e -3.8 Unexplained
X -4.2 Unexplained
XI X -4.5 Unstable beam, reported to the SSDL
XII Co-60 -5.0 Wrong indication of the telemeter 
Co-60 5.7 Error in multiplication of the coefficients
X 4.8 Unstable beam but also some calculation errors
XIII e 4.7 Many errors: the physicist made a large error (19%) in chamber perturbation correction factor; a value for
a diameter was used as the value for chamber radius.
There were also other mistakes: in the applied value of stopping powerwater-to-air ratio, in the applied
value of the displacement of the effective point of measurement, calculation errors. Luckily, the other
errors in combination with 19% error cancelled off giving as a result the error of 4.7%.
X 4.2 The ionization chamber measurements performed in the polystyrene phantom at the depth different than
the correct reference depth
XIV X -4.9 Increase of calibration coefficient by 3.9% since the last chamber calibration (not controlled by the
physicist with the Sr-90 source) and the use of a wrong value of the perturbation factor
XVI Co-60 4.3 Unexplained
In all cases of unexplained deviations the measurements were repeated
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solve the problem over a telephone conversation, however
if considered necessary, the physicist from the SSDL
visited the participating centre to verify the measurements
using a SSDL dosimeter with an ionisation chamber.
Table III presents explanations of the discrepancies
found during the audits, as discussed with the participants,
and analysed by the SSDL.
There is no doubt that in 10 cases the discrepancies
were caused by lack of experience of the physicist or
by his/her mistakes. Among 8 unexplained deviations,
7 concerned the beams of the Neptun accelerators. The
participants complained about the instability of these
machines. This explanation is probable, especially if the
beam output was not measured immediately before
the TLD irradiation. In those cases where a logical
explanation of discrepancies could not be found the
measurements were repeated. In some other cases the
reported data sheets revealed not only deviations
exceeding the acceptance level, but also calculation errors,
mistakes in reading the coefficients from the data in the
dosimetry protocol, and lack of full understanding of the
protocol. Luckily, some of the errors cancelled off each
other. All these errors and misinterpretations were
discussed with the participants, explained and corrected.
In case of three centres (I, II, X, in Tab. III), participating
in all the audits, we detected no deviations beyond the
acceptance level. In the case of centre XI (deviation of
4.5%), the physicist irradiated the capsules being aware of
the beam instability and reporting this to the SSDL (the
treatments were stopped). The results from these four
centres confirm their high standards in dosimetry and
quality assurance. The results of the latest run (2001)
give hope that such high standards may be maintained
in all centres.
It was extremely difficult to estimate the number of
patients who could be irradiated with doses different to
the prescribed ones, because in the opinion of the
participants, some of the errors detected might have
occurred only during the TLD irradiation. It was stated
beyond doubt that deviations of 12.1% and -5.0% (first
audit of Co-60 units in centres VI and XII respectively)
did not influence the patients. In both cases the mistakes
were made during the audit. In the first case, however
the physicist did not compare the output used for patient
treatment with that reported in the TLD data sheet. It
was also stated that in two cases the errors in dosimetry
resulted in over or underdosage of the patients. In the
case of centre XII (a deviation of 5.7%), the error was
reproduced in the output used for patient treatments: 78
patients were underdosed for about one month. In the
case of centre XIV (a deviation of 4.9%) the patients
were overdosed for about two years.
Conclusions
1. The establishment of a voluntary, TLD based postal
audit system for dosimetry in radiotherapy has
proved to be effective in assuring the quality of dose
determination in radiotherapy.
2. The results of the study demonstrate that it is
possible to keep the dose determination (using an
ionisation chamber in reference geometry) within
acceptance limits by implementation of correct
methodology and carefully carried-out measure-
ments and calculations of doses.
3. A detailed data sheet allows to evaluate the impact
of procedural errors on the final results, and should
be introduced in every kind of a TLD postal audit.
4. The audits should be extended to non-standard
conditions, especially such, in which the dose is also
determined by the treatment planning system (TPS).
5. The experience gained from these investigations
indicates that there is a need for physicists employed
in radiotherapy centres to undergo continuous
training in dosimetry.
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